We found significant diurnal rhythmicity of the Casr gene, peaking in the inactive phase, and by timing Cinacalcet treatment to this peak we achieved a marked inhibition of the severely increased parathyroid proliferation in sHPT to a level below the proliferative rate of normal parathyroid cells not subjected to uremia. The gene discussed is CASR; the disease is uremia.